AbbVie
ABBV
#27
Rank
S$580.56 B
Marketcap
S$328.60
Share price
0.04%
Change (1 day)
33.61%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$184.73 Billion

According to AbbVie's latest financial reports the company's total liabilities are S$184.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$176.13 B-1.68%
2024-12-31S$179.14 B9.12%
2023-12-31S$164.18 B0.78%
2022-12-31S$162.90 B-8.08%
2021-12-31S$177.22 B-2.55%
2020-12-31S$181.86 B38.66%
2019-12-31S$131.16 B41.61%
2018-12-31S$92.62 B5.42%
2017-12-31S$87.85 B-1.23%
2016-12-31S$88.95 B28.07%
2015-12-31S$69.46 B103.98%
2014-12-31S$34.05 B8.79%
2013-12-31S$31.30 B8.25%
2012-12-31S$28.91 B194.21%
2011-12-31S$9.82 B40.47%
2010-12-31S$6.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$151.34 B-18.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$110.24 B-40.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$107.57 B-41.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$13.98 B-92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$42.41 B-77.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$85.70 B-53.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$86.03 B-53.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$77.71 B-57.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.93 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA